HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cosmo Damiano Gadaleta Selected Research

Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)

1/2018C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients.
9/2017The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients.
7/2014Possible biological and translational significance of mast cells density in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cosmo Damiano Gadaleta Research Topics

Disease

31Neoplasms (Cancer)
01/2022 - 07/2009
10Neoplasm Metastasis (Metastasis)
01/2020 - 01/2014
7Hyperthermia
11/2021 - 10/2014
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2014
6Hepatocellular Carcinoma (Hepatoma)
12/2020 - 12/2011
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2011
4Stomach Neoplasms (Stomach Cancer)
04/2018 - 02/2015
4Breast Neoplasms (Breast Cancer)
01/2018 - 07/2009
3Adenocarcinoma
01/2022 - 01/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 07/2014
2Disease Progression
10/2020 - 09/2017
2Systemic Mastocytosis
06/2020 - 07/2014
2Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2020
2Rectal Neoplasms (Rectal Cancer)
01/2019 - 01/2014
2Melanoma (Melanoma, Malignant)
01/2017 - 07/2014
2Liver Neoplasms (Liver Cancer)
05/2015 - 01/2014
2Hypersensitivity (Allergy)
07/2014 - 01/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2011 - 02/2010
1Legionnaires' Disease (Legionnaire's Disease)
01/2022
1Kidney Neoplasms (Kidney Cancer)
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Diabetes Mellitus
11/2021
1Peripheral Nervous System Diseases (PNS Diseases)
02/2021
1Ovarian Epithelial Carcinoma
10/2020
1Mast-Cell Leukemia (Leukemia, Mast Cell)
06/2020
1Rare Diseases (Rare Disease)
06/2020
1Hypoxia (Hypoxemia)
09/2017
1Renal Cell Carcinoma (Grawitz Tumor)
09/2017
1Lymphatic Metastasis
11/2016
1Bone Resorption
10/2015
1Mastocytosis
03/2015
1Hypothermia
10/2014
1Multiple Myeloma
07/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2014
1Prostatic Neoplasms (Prostate Cancer)
07/2014
1Dermatofibrosarcoma
02/2014
1Sarcoma (Soft Tissue Sarcoma)
02/2014
1Bone Diseases (Bone Disease)
01/2014

Drug/Important Bio-Agent (IBA)

18Tryptases (Tryptase)IBA
01/2021 - 07/2009
7Biological ProductsIBA
01/2020 - 02/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 02/2010
4Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2014
4Sorafenib (BAY 43-9006)FDA Link
12/2020 - 07/2014
4Peptide Hydrolases (Proteases)FDA Link
04/2017 - 03/2013
3Gabexate (Foy)IBA
01/2021 - 01/2014
3masitinibIBA
01/2021 - 07/2014
3Bevacizumab (Avastin)FDA Link
01/2020 - 01/2017
3Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
01/2018 - 07/2014
2Pharmaceutical PreparationsIBA
11/2021 - 01/2016
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 01/2019
2nafamostatIBA
10/2015 - 01/2014
2Imatinib Mesylate (Gleevec)FDA Link
10/2015 - 02/2014
2Serine Proteases (Serine Protease)IBA
07/2014 - 07/2009
2pazopanibFDA Link
07/2014 - 02/2014
1folfirinoxIBA
01/2022
1Taxoids (Taxanes)IBA
02/2021
1Vinca AlkaloidsIBA
02/2021
1Paclitaxel (Taxol)FDA LinkGeneric
10/2020
1Antineoplastic Agents (Antineoplastics)IBA
10/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
01/2018
1130-nm albumin-bound paclitaxelIBA
01/2018
1Tumor Biomarkers (Tumor Markers)IBA
09/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2017
1Amino AcidsFDA Link
09/2017
1Glucose (Dextrose)FDA LinkGeneric
09/2017
12,2,3,3-tetramethylcyclopropane carboxamideIBA
04/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2017
1LigandsIBA
02/2017
1Angiogenesis InhibitorsIBA
01/2017
1Chemokine CXCL1IBA
01/2017
1CytokinesIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
03/2016
1MicroRNAs (MicroRNA)IBA
03/2016
1Irinotecan (Camptosar)FDA LinkGeneric
01/2016
1Monoclonal AntibodiesIBA
01/2016
1S- (N- monomethoxytritylaminoethyl)- O- (2- chlorophenyl)phosphorothioateIBA
10/2015
1Axitinib (AG 013736)IBA
07/2014
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
07/2014
1Sunitinib (Sutent)FDA Link
07/2014
1tivozanibIBA
07/2014
1PAR-2 ReceptorIBA
07/2014
1Diphosphonates (Bisphosphonates)IBA
01/2014
1tranilastIBA
01/2014
1Radioisotopes (Radionuclides)IBA
12/2011
1Peptide Receptors (Peptide Receptor)IBA
12/2011

Therapy/Procedure

21Therapeutics
11/2021 - 12/2011
11Drug Therapy (Chemotherapy)
01/2022 - 01/2017
2Intra-Arterial Infusions
01/2022 - 01/2022
2Radiotherapy
11/2021 - 01/2020
2Electrodes (Electrode)
01/2020 - 10/2014
1Vascular Access Devices (Arterial Line)
01/2022
1Cryosurgery
11/2021
1Immunotherapy
09/2021
1Palliative Care (Palliative Therapy)
01/2020
1Precision Medicine
03/2016
1Salvage Therapy
01/2016
1Radiofrequency Ablation
01/2014
1Radioimmunotherapy
12/2011